A detailed history of J.Safra Asset Management Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, J.Safra Asset Management Corp holds 1,176 shares of ABBV stock, worth $231,460. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,176
Previous 281 318.51%
Holding current value
$231,460
Previous $51,000 294.12%
% of portfolio
0.02%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

BUY
$154.79 - $180.76 $138,537 - $161,780
895 Added 318.51%
1,176 $201,000
Q1 2024

May 09, 2024

SELL
$159.82 - $182.1 $118,586 - $135,118
-742 Reduced 72.53%
281 $51,000
Q4 2023

Feb 02, 2024

SELL
$137.6 - $154.97 $35,088 - $39,517
-255 Reduced 19.95%
1,023 $158,000
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $176,760 - $211,981
1,278 New
1,278 $206,000
Q2 2022

Aug 01, 2022

SELL
$137.62 - $174.96 $6,468 - $8,223
-47 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$131.98 - $163.75 $6,203 - $7,696
47 New
47 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $348B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track J.Safra Asset Management Corp Portfolio

Follow J.Safra Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J.Safra Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on J.Safra Asset Management Corp with notifications on news.